Map Purified Efficient Safe Reliable Flexible Effective

For consistent, predictable sedation and reversal, rely on the purified formulation of alpha-2 agonist, DEXDOMITOR® (dexmedetomidine), along with antagonist ANTISEDAN® (atipamezole). These solutions are safe, reliable and only available from Zoetis.

Dexdomitor Antisedan

Important Safety Information

Do not use DEXDOMITOR in dogs or cats and ANTISEDAN in dogs with cardiovascular disease, respiratory disorders, liver or kidney diseases, or in conditions of shock, severe debilitation, or stress due to extreme heat, cold or fatigue. DEXDOMITOR should not be administered in the presence of preexisting hypotension, hypoxia, or bradycardia. As with all a2-adrenoceptor agonists, the potential for isolated cases of hypersensitivity, including paradoxical response (excitation), exists with DEXDOMITOR. The use of DEXDOMITOR as a preanesthetic in dogs and cats significantly reduces the amount of induction and maintenance anesthetic requirements. Careful patient monitoring is necessary to avoid anesthetic overdose. Arrhythmias, bradycardia, apnea, emesis, convulsions, hypersalivation may occur with DEXDOMITOR use. Severe dyspnea and respiratory crackles due to acute or delayed pulmonary edema could develop in cats. DEXDOMITOR has not been evaluated for use in breeding, pregnant, or lactating dogs or cats; in dogs younger than 16 weeks of age or in cats younger than 12 weeks of age; in geriatric dogs or cats. Occasional vomiting may occur with ANTISEDAN use. Rarely, a brief state of excitement or apprehensiveness may be seen in ANTISEDAN treated dogs. Other potential side effects of a2-antagonists, such as ANTISEDAN, include hypersalivation, diarrhea, and tremors. For more safety information, refer to the Full Prescribing Information.

DEXDOMITOR and ANTISEDAN are trademarks owned by Orion Corporation and Orion Pharma. These products are developed and manufactured by Orion Corporation Orion Pharma Finland and distributed by Zoetis Inc. ©2013 Zoetis Inc. All rights reserved. February 2013. PAS1212010